These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 26598634)

  • 21. Use of Atomized Intranasal Tranexamic Acid as an Adjunctive Therapy in Difficult-to-Treat Epistaxis.
    Sarkar D; Martinez J
    J Spec Oper Med; 2019; 19(2):23-28. PubMed ID: 31201748
    [TBL] [Abstract][Full Text] [Related]  

  • 22. BET 1: should tranexamic acid be given to patients who are having an upper gastrointestinal bleed?
    Morgan A; Jeffrey-Smith A
    Emerg Med J; 2012 Sep; 29(9):773-7. PubMed ID: 22903425
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tranexamic Acid for Epistaxis--A Promising Treatment That Deserves Further Study.
    Clinkard D; Barbic D
    CJEM; 2016 Jan; 18(1):72-3. PubMed ID: 26088087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of epistaxis in hereditary hemorrhagic telangiectasia with tranexamic acid - a double-blind placebo-controlled cross-over phase IIIB study.
    Geisthoff UW; Seyfert UT; Kübler M; Bieg B; Plinkert PK; König J
    Thromb Res; 2014 Sep; 134(3):565-71. PubMed ID: 25005464
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluating Effectiveness of Nasal Compression With Tranexamic Acid Compared With Simple Nasal Compression and Merocel Packing: A Randomized Controlled Trial.
    Akkan S; Çorbacıoğlu ŞK; Aytar H; Emektar E; Dağar S; Çevik Y
    Ann Emerg Med; 2019 Jul; 74(1):72-78. PubMed ID: 31080025
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of epistaxes in hereditary haemorrhagic telangiectasia (Rendu-Osler-Weber disease) with tranexamic acid].
    Morales-Angulo C; Pérez del Molino A; Zarrabeitia R; Fernández A; Sanz-Rodríguez F; Botella LM
    Acta Otorrinolaringol Esp; 2007 Apr; 58(4):129-32. PubMed ID: 17428407
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative Effectiveness of Topically Administered Tranexamic Acid Versus Topical Oxymetazoline Spray for Achieving Hemostasis in Epistaxis.
    Whitworth K; Johnson J; Wisniewski S; Schrader M
    J Emerg Med; 2020 Feb; 58(2):211-216. PubMed ID: 31899024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Topical use of tranexamic acid for the management of post-procedural rectal bleeding.
    Altawil Z; Gendron BJ; Schechter-Perkins EM
    Am J Emerg Med; 2019 Jan; 37(1):173.e3-173.e4. PubMed ID: 30343959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epistaxis complicated by rivaroxaban managed with topical tranexamic acid.
    Utkewicz MD; Brunetti L; Awad NI
    Am J Emerg Med; 2015 Sep; 33(9):1329.e5-7. PubMed ID: 25895714
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparison between intravenous and intra-articular regimens of tranexamic acid in reducing blood loss during total knee arthroplasty.
    Soni A; Saini R; Gulati A; Paul R; Bhatty S; Rajoli SR
    J Arthroplasty; 2014 Aug; 29(8):1525-7. PubMed ID: 24814890
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nasal Powder Formulation of Tranexamic Acid and Hyaluronic Acid for the Treatment of Epistaxis.
    Gomes Dos Reis L; Ghadiri M; Young P; Traini D
    Pharm Res; 2020 Sep; 37(10):186. PubMed ID: 32888133
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravenous tranexamic acid and intraoperative visualization during functional endoscopic sinus surgery: a double-blind randomized controlled trial.
    Langille MA; Chiarella A; Côté DW; Mulholland G; Sowerby LJ; Dziegielewski PT; Wright ED
    Int Forum Allergy Rhinol; 2013 Apr; 3(4):315-8. PubMed ID: 23044919
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Local antifibrinolytic treatment with tranexamic acid in hemophilic children undergoing dental extractions.
    Waly NG
    Egypt Dent J; 1995 Jan; 41(1):961-8. PubMed ID: 9497628
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Battlefield administration of tranexamic acid by combat troops: a feasibility analysis.
    Wright C
    J R Army Med Corps; 2014 Dec; 160(4):271-2. PubMed ID: 24155347
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tranexamic acid and bevacizumab in hereditary hemorrhagic telangiectasia patients presenting with epistaxis.
    Lacout A; Marcy PY; El Hajjam M; Lacombe P
    Cutis; 2013 Apr; 91(4):173-4. PubMed ID: 23763075
    [No Abstract]   [Full Text] [Related]  

  • 36. Evaluating three hundred and fifty-two admissions and predictors of re-admissions for epistaxis - is it time to re-evaluate tranexamic acid in epistaxis?
    Jervis S; Saunders T; Belcher J; Skinner D
    Clin Otolaryngol; 2017 Apr; 42(2):439-442. PubMed ID: 26681525
    [No Abstract]   [Full Text] [Related]  

  • 37. A retrospective analysis of blood loss with combined topical and intravenous tranexamic acid after coronary artery bypass graft surgery.
    Mahaffey R; Wang L; Hamilton A; Phelan R; Arellano R
    J Cardiothorac Vasc Anesth; 2013 Feb; 27(1):18-22. PubMed ID: 23063104
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BET 1: The role of topical phenylephrine in non-traumatic epistaxis.
    Howard L; Baombe J
    Emerg Med J; 2019 Sep; 36(9):572-573. PubMed ID: 31427476
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Towards evidence-based emergency medicine: best BETs from the Manchester Royal Infirmary. BET 2: Routine coagulation testing in adult patients with epistaxis.
    Hodgson D; Burdett-Smith P
    Emerg Med J; 2011 Jul; 28(7):633-4. PubMed ID: 21700749
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tranexamic acid in the trauma patient.
    Gaines-Dillard N; Bartley MK; Rosini JM
    Nursing; 2016 Feb; 46(2):60-2. PubMed ID: 26760392
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.